Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

[1]  C. Chung,et al.  PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis , 2009, Proceedings of the National Academy of Sciences.

[2]  Takao Shimizu,et al.  Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. , 2009, Annual review of pharmacology and toxicology.

[3]  M. Mathru.  Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective , 2009 .

[4]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[5]  P. Libby,et al.  The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models , 2008, Nature Reviews Immunology.

[6]  J. V. Sarma,et al.  Adverse functions of IL‐17A in experimental sepsis , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  M. Perretti,et al.  Novel insights into the inhibitory effects of Galectin‐1 on neutrophil recruitment under flow , 2008, Journal of leukocyte biology.

[8]  P. Singer,et al.  Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective , 2008, Intensive Care Medicine.

[9]  Charles N. Serhan,et al.  Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.

[10]  C. Mackay,et al.  Functional roles for C5a receptors in sepsis , 2008, Nature Medicine.

[11]  D. Rittirsch,et al.  Immunodesign of experimental sepsis by cecal ligation and puncture , 2008, Nature Protocols.

[12]  M. Teixeira,et al.  The Required Role of Endogenously Produced Lipoxin A4 and Annexin-1 for the Production of IL-10 and Inflammatory Hyporesponsiveness in Mice1 , 2007, The Journal of Immunology.

[13]  J. Sunderram,et al.  Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: A trend analysis from 1993 to 2003* , 2007, Critical care medicine.

[14]  M. Berger,et al.  Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects , 2007, Intensive Care Medicine.

[15]  Yan Lu,et al.  Mediator lipidomics: search algorithms for eicosanoids, resolvins, and protectins. , 2007, Methods in enzymology.

[16]  Javed Siddiqui,et al.  Circulating Cytokine/Inhibitor Profiles Reshape the Understanding of the SIRS/CARS Continuum in Sepsis and Predict Mortality1 , 2006, The Journal of Immunology.

[17]  S. Moncada,et al.  The discovery of nitric oxide and its role in vascular biology , 2006, British journal of pharmacology.

[18]  M. Sitkovsky,et al.  Model organisms: Animal Models of sepsis: setting the stage , 2005, Nature Reviews Drug Discovery.

[19]  M. Perretti,et al.  Annexin 1‐deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro , 2005, Journal of leukocyte biology.

[20]  B. Spur,et al.  First Total Synthesis of 7(S),16(R),17(S)‐Resolvin D2, a Potent Antiinflammatory Lipid Mediator. , 2005 .

[21]  L. Ignarro,et al.  Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  B. Spur,et al.  First total synthesis of 7(S),16(R),17(S)-Resolvin D2, a potent anti-inflammatory lipid mediator , 2004 .

[23]  D. Gilroy,et al.  15-epi-lipoxin A4–mediated Induction of Nitric Oxide Explains How Aspirin Inhibits Acute Inflammation , 2004, The Journal of experimental medicine.

[24]  Adriano G. Rossi,et al.  Inflammatory Resolution: new opportunities for drug discovery , 2004, Nature Reviews Drug Discovery.

[25]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[26]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[27]  C. Serhan,et al.  Resolvins , 2002, The Journal of experimental medicine.

[28]  C. Clish,et al.  Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. , 1998, The Journal of clinical investigation.

[29]  T. Kodama,et al.  The Macrophage Scavenger Receptor Type A Is Expressed by Activated Macrophages and Protects the Host Against Lethal Endotoxic Shock , 1997, The Journal of experimental medicine.

[30]  C. Anderson,et al.  PERINATAL NUTRITION ENRICHED WITH OMEGA‐3 POLYUNSATURATED FATTY ACIDS ATTENUATES ENDOTOXIC SHOCK IN NEWBORN RATS , 1996, Shock.

[31]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Snyder.  Platelet-Activating Factor and Related Lipid Mediators , 1987, Springer US.

[33]  B. Samuelsson,et al.  Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Crawford,et al.  Setting the stage. , 2021, The New England journal of medicine.